FinVolution (FINV) Files Form 6-K; Q1 2025 MD&A & Financials Available

FinVolution Group (symbol: FINV) has submitted a Form 6-K to the U.S. Securities and Exchange Commission for the month of June 2025.

Rhea-AI Filing Summary

FinVolution Group (symbol: FINV) has submitted a Form 6-K to the U.S. Securities and Exchange Commission for the month of June 2025. The filing is principally an administrative cover document that confirms the company’s status as a foreign private issuer reporting under Form 20-F. No financial figures, earnings data, or narrative discussion are included in the supplied text.

The document lists two exhibits that are not provided here: (1) Exhibit 99.1 — Management’s Discussion and Analysis of Financial Condition and Results of Operations, and (2) Exhibit 99.2 — Unaudited Interim Condensed Consolidated Financial Statements for the three-month periods ended March 31, 2024 and 2025. These exhibits would normally contain the substantive operating commentary and interim results, but their contents are unavailable in the excerpt.

The filing is signed by Chief Financial Officer Jiayuan Xu and dated 20 June 2025. Because the critical exhibits are absent, investors do not yet have access to revenue, profitability, balance-sheet metrics, or forward-looking commentary. Consequently, this Form 6-K serves mainly as a procedural notice that detailed Q1 2025 information exists and can be consulted in the full submission on the SEC’s EDGAR system.

Insights

SEC Filing Analyst

TL;DR: Procedural 6-K cover; no numbers disclosed, impact neutral pending exhibit review.

The submitted excerpt is a barebones cover page for FinVolution’s June 2025 Form 6-K. It signals that the company has prepared an MD&A and unaudited Q1 2025 statements, but none of the data has been provided here. Without revenue, margin, credit-quality, or guidance details, the filing does not alter the investment thesis. Market participants will deem the disclosure routine until they access Exhibits 99.1 and 99.2 on EDGAR. Therefore, the immediate market impact is neutral; any positive or negative reassessment will hinge on the yet-to-be-reviewed financial statements.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did FinVolution (FINV) file a Form 6-K in June 2025?

The company submitted the form to furnish its Q1 2025 MD&A and unaudited interim financial statements to the SEC.

What exhibits are referenced in FinVolution’s June 2025 Form 6-K?

Exhibit 99.1 is the MD&A, and Exhibit 99.2 contains unaudited interim condensed consolidated financial statements for Q1 2024 and Q1 2025.

Does the provided 6-K excerpt include financial results or guidance?

No. The excerpt is limited to the cover page and signature; it contains no financial metrics or projections.

Who signed FinVolution’s June 2025 Form 6-K?

Chief Financial Officer Jiayuan Xu signed the document on behalf of the company.

Where can investors find the full MD&A and financial statements mentioned?

Investors should access the complete Form 6-K filing, including Exhibits 99.1 and 99.2, via the SEC’s EDGAR database.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/20/2025 - 06:03 AM Learn about SEC filing dates

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of June 2025

—————

 

Commission File Number: 001-38269

—————

 

FinVolution Group

 

Building G1, No. 999 Dangui Road

Pudong New District, Shanghai 201203

The People’s Republic of China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F   X   Form 40-F      

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 	FinVolution Group
 	 	 
 	By:	/s/ Jiayuan Xu
 	Name:	Jiayuan Xu
 	Title:	Chief Financial Officer

 

Date: June 20, 2025

 

 

 

 

Exhibit Index

 

Exhibit 99.1—Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Exhibit 99.2—Unaudited Interim Condensed Consolidated Financial Statements for the Three Months Periods Ended March 31, 2024 and 2025